EP2515941
PHARMACEUTICAL FORMULATION OF BEVACIZUMAB
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.12.2010EP published:
13.11.2019EP application number:
10798236.5
EPO information:
European Patent Register
Max expiry date:
19.12.2030
Title:
PHARMACEUTICAL FORMULATION OF BEVACIZUMAB
Timeline
Today
20.12.2010EP application
13.11.2019EP Publication
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070, Basel, CH
Inventor
Name:
GOKARN, Yatin, R.Address:
South San FranciscoCalifornia, US
Name:
KAMERZELL, Timothy, J.Address:
Overland ParkKansas, US
Name:
LI, MeganAddress:
South San FranciscoCalifornia, US
Name:
CROMWELL, MaryAddress:
South San FranciscoCalifornia, US
Name:
LIU, HongAddress:
South San FranciscoCalifornia, US
Priority
Number:
288535 PDate:
21.12.2009Country:
US
Classification
Categories:
A61K 39/395, A61K 9/00, A61K 47/18, A61K 47/26